Andy Williams

CEO

Medicine Man

Andy Williams is among America’s most pioneering thought leaders and entrepreneurs in the legal cannabis space.
As co-founder and CEO of celebrated retail cannabis chain Medicine Man, Williams has already fulfilled his vision of becoming “the Costco of marijuana.” As co-founder and chairman of the board of industry-leading consultancy Medicine Man Technologies, Williams has expanded his influence exponentially—helping entrepreneurs in other states via his extensive cultivation expertise and unparalleled business acumen. And now as a founding partner in phytopharmaceutical company MedPharm, Williams is investing heavily into the future of pharmaceutical-grade cannabis research.
With years of experience in the world’s first regulated market, Williams is a leading expert on the cannabis industry featured in The New York Times, Rolling Stone, CNN, The Wall Street Journal, BBC and the MSNBC docu-series “Pot Barons,” which focused on Williams as one of the show’s central characters.
Williams continues to elevate his politically active leadership in the ever-expanding marijuana industry, working daily to protect and grow the cannabis industry as a board member with the New Federalism Fund, which works federally on tax reform and other industry-specific issues, and Colorado Leads, a pro-growth organization focusing its efforts locally.
He also serves as a board member for Flatiron Venture Partners, LLC and the American Trade Association for Cannabis and Hemp and as a voting member on ASTM Committee D37 on Cannabis, which is currently developing important standards for cannabis, its products and processes for the esteemed worldwide standards organization.
In addition to his regular financial support for Students for Sensible Drug Policy and other industry organizations, Williams is proud to serve as co-founder and director of the Medicine Man Family Foundation, a community-focused nonprofit investing in impact-driven projects rooted in the communities in which the Medicine Man brand operates.